ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Outset Medical, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – OM

Core Viewpoint - Rosen Law Firm is reminding purchasers of Outset Medical, Inc. securities of the upcoming lead plaintiff deadline for a class action lawsuit related to misleading statements made by the company during the class period from August 1, 2022, to August 7, 2024 [1]. Group 1: Class Action Details - Investors who purchased Outset Medical securities during the specified class period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by October 28, 2024 [3]. - Investors can join the class action by visiting the provided link or contacting the law firm directly for more information [6]. Group 2: Case Background - The lawsuit alleges that during the class period, Outset Medical made false and misleading statements regarding its Tablo products, including marketing for unapproved uses and lacking the necessary sales infrastructure [5]. - Specific claims include that Outset Medical was likely to submit an additional 510(k) application for the Tablo products and that there was a substantial risk of ceasing sales pending FDA approval [5]. - The lawsuit asserts that these misleading statements adversely impacted the company's revenue growth and caused investor damages when the truth was revealed [5]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions, highlighting its own achievements in this area [4]. - The firm has secured significant settlements for investors, including over $438 million in 2019 alone, and has been recognized as a leader in the field of securities class action litigation [4].